Literature DB >> 12529686

Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Tuebingen experience.

H Kreyenberg1, W Hölle, S Möhrle, D Niethammer, P Bader.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12529686     DOI: 10.1038/sj.leu.2402761

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  13 in total

1.  Single nucleotide polymorphism-based system improves the applicability of quantitative PCR for chimerism monitoring.

Authors:  Egle Gineikiene; Mindaugas Stoskus; Laimonas Griskevicius
Journal:  J Mol Diagn       Date:  2008-12-04       Impact factor: 5.568

2.  Detection and quantification of chimerism by droplet digital PCR.

Authors:  David George; Juliann Czech; Bobby John; Min Yu; Lawrence J Jennings
Journal:  Chimerism       Date:  2013-06-20

3.  Indel analysis by droplet digital PCR: a sensitive method for DNA mixture detection and chimerism analysis.

Authors:  Ana Santurtún; José A Riancho; Jana Arozamena; Mónica López-Duarte; María T Zarrabeitia
Journal:  Int J Legal Med       Date:  2016-07-22       Impact factor: 2.686

4.  Monitoring of hematopoietic chimerism by real-time quantitative PCR of micro insertions/deletions in samples with low DNA quantities.

Authors:  Christian Bach; Elmira Tomova; Katja Goldmann; Volker Weisbach; Wolf Roesler; Andreas Mackensen; Julia Winkler; Bernd M Spriewald
Journal:  Transfus Med Hemother       Date:  2014-12-22       Impact factor: 3.747

5.  NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromes.

Authors:  Nicolaus Kröger; Ulrike Bacher; Peter Bader; Sebastian Böttcher; Michael J Borowitz; Peter Dreger; Issa Khouri; Homer A Macapinlac; Homer Macapintac; Eduardo Olavarria; Jerald Radich; Wendy Stock; Julie M Vose; Daniel Weisdorf; Andre Willasch; Sergio Giralt; Michael R Bishop; Alan S Wayne
Journal:  Biol Blood Marrow Transplant       Date:  2010-06-14       Impact factor: 5.742

6.  Quantitative chimerism: an independent acute leukemia prognosis indicator following allogeneic hematopoietic SCT.

Authors:  X-Y Qin; G-X Li; Y-Z Qin; Y Wang; F-R Wang; D-H Liu; L-P Xu; H Chen; W Han; J-Z Wang; X-H Zhang; J-L Li; L-D Li; K-Y Liu; X-J Huang
Journal:  Bone Marrow Transplant       Date:  2014-08-04       Impact factor: 5.483

7.  Increasing chimerism after allogeneic stem cell transplantation is associated with longer survival time.

Authors:  Xiaowen Tang; Gheath Alatrash; Jing Ning; Haroon Jakher; Patricia Stafford; Madhushree Zope; Elizabeth J Shpall; Roy B Jones; Richard E Champlin; Peter F Thall; Borje S Andersson
Journal:  Biol Blood Marrow Transplant       Date:  2014-04-13       Impact factor: 5.742

8.  Hematopoietic chimerism monitoring based on STRs: quantitative platform performance on sequential samples.

Authors:  Don Kristt; Moshe Israeli; Ronit Narinski; Hagit Or; I Yaniv; Jerry Stein; Tirza Klein
Journal:  J Biomol Tech       Date:  2005-12

9.  The use of imatinib mesylate as a lifesaving treatment of chronic myeloid leukemia relapse after bone marrow transplantation.

Authors:  Monika Conchon; Sabri S Sanabani; Israel Bendit; Carla Luana Dinardo; Lucia Dias; Dalton de Alencar Fischer Chamone; Pedro Enrique Dorlhiac-Llacer; Frederico Luiz Dulley
Journal:  J Transplant       Date:  2009-10-22

10.  Mixed T cell lineage chimerism in acute leukemia/MDS using pre-emptive donor lymphocyte infusion strategy-Is it prognostic?-a single-center retrospective study.

Authors:  Donal Mclornan; Kavita Raj; Vipul Sheth; Victoria Potter; Hugues de Lavallade; Shreyans Gandhi; Austin Kulasekararaj; Pramila Krishnamurthy; Varun Mehra; Francesco Dazzi; Ghulam Mufti; Antonio Pagliuca
Journal:  Blood Cancer J       Date:  2021-07-12       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.